Notice Concerning The Initiation Of Pediatric Phase Iii Clinical Trial Of Kd-414, A Covid-19 Vaccine Effective Against Mutant Strains
06/12/2023 01:01
Dec 6 (Reuters) - Meiji Holdings Co Ltd 2269.T :
* MEIJI HOLDINGS CO LTD: NOTICE CONCERNING THE INITIATION OF
PEDIATRIC PHASE III CLINICAL TRIAL OF KD-414, A COVID-19 VACCINE
EFFECTIVE AGAINST MUTANT STRAINS
Source text for Eikon: ID:nTSxf925d3
Further company coverage: 2269.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))